
Masthead Maestro: Q&A with Manuel Tena-Sempere, MD, PhD, the Next Editor-in-Chief of Endocrinology

Masthead Maestro: Q&A with Manuel Tena-Sempere, MD, PhD, the Next Editor-in-Chief of Endocrinology
High Time: Addressing Research Gaps in Opioid-Associated Endocrine Conditions
Eli Lilly Cuts Insulin Prices by 70% and Caps Patient Insulin Out-of-Pocket Costs at $35 Per Month
The Time Is Always Now: The Endocrine Society’s Call to Eliminate Racism in Endocrinology
Never Too Late to Do Good: The Redemption of Stanley Andrisse, PhD, MBA